Stockscreener 앱 받기
1.95
3.99%
0.07
전일 마감가:
$1.88
열려 있는:
$1.86
하루 거래량:
93,643
Relative Volume:
0.02
시가총액:
$7.95M
수익:
$79,300
순이익/손실:
$-6.92M
주가수익비율:
-3.0555
EPS:
-0.6382
순현금흐름:
$-5.34M
1주 성능:
+2.89%
1개월 성능:
+19.94%
6개월 성능:
+147.12%
1년 성능:
+739.06%
1일 변동 폭
$1.82
$1.9606
1주일 범위
$1.76
$2.03
52주 변동 폭
$0.1299
$8.9999
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
VRAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| VRAX | 1.955 | 7.95M | 79,300 | -6.92M | -5.34M | -0.6382 |
| VRTX | 449.94 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.47 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.78 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.56 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.25 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Virax Biolabs Group Ltd 주식(VRAX)의 최신 뉴스
Virax Biolabs Sees Asset Growth Amid Financial Loss - TipRanks
ARMISTICE CAPITAL, LLC Acquires New Stake in Virax Biolabs Group Ltd - GuruFocus.com
Virax Biolabs announces 2024 annual meeting - Investing.com India
Virax Biolabs announces 2024 annual meeting By Investing.com - Investing.com UK
Virax Biolabs Sets Date for 2024 AGM - TipRanks
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN
Virax Biolabs announces distribution agreement with Europa Biosite - TipRanks
Virax Biolabs Expands Reach with Europa Biosite Deal - TipRanks
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland - Yahoo Finance
Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews
Analyzing the Impact of Earnings Reports on Virax Biolabs Group Ltd Inc. (VRAX) Price Performance - The InvestChronicle
Daily Progress: Virax Biolabs Group Ltd (VRAX) Gain 14.20, Closing at 1.85 - The Dwinnex
Virax Biolabs Plans New Share Offering - TipRanks
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - MSN
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 72.2% in September - Defense World
Charting the Course: Virax Biolabs Group Ltd’s VRAX Stock Prospects - The InvestChronicle
How did Virax Biolabs Group Ltd (VRAX) fare last session? - US Post News
Daily Market Movement: Virax Biolabs Group Ltd (VRAX) Sees a -3.56 Decrease, Closing at 2.44 - The Dwinnex
Virax Biolabs Group Ltd (VRAX)’s Day in Review: Closing at 2.84, Up by 9.65 - The Dwinnex
Virax Biolabs Group Ltd Inc. (VRAX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
A closer look at VRAX’s price-to-free cash flow ratio - US Post News
Cosmos Health expands mpox kit distribution to Gulf States - Investing.com India
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Lelezard
Ratios Reveal: Breaking Down Virax Biolabs Group Ltd (VRAX)’s Financial Health - The Dwinnex
VRAX’s 2023 Market Dance: Up 140.41% – Time to Invest? - The InvestChronicle
Investing in Virax Biolabs Group Ltd (VRAX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Closing Figures Unveiled: Virax Biolabs Group Ltd (VRAX) Drop -12.90, Closes at 3.51 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) requires closer examination - US Post News
Post-Trade Analysis: Virax Biolabs Group Ltd (VRAX) Slides -7.91, Closing at 4.66 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Luminar Technologies Inc (NASDAQ: LAZR) Shares Look Bullish In 2024 - Stocks Register
NuCana halts NuTide:323 study on colorectal cancer - Investing.com
NuCana halts NuTide:323 study on colorectal cancer By Investing.com - Investing.com Australia
Virax Biolabs to Participate at 7th European Congress of Immunology - Quantisnow
Wall Street-Heavily Traded - WDRB
Russia bans entry to dozens of American journalists, including WSJ, NYT and Washington Post - CNN International
Virax stock soars on Mpox tests deal in Europe and Middle East - Invezz
Virax Biolabs expands Mpox test kit distribution in Europe, GCC By Investing.com - Investing.com Australia
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - Yahoo Finance
Virax Biolabs signs distribution agreement for Mpox virus detection kits - TipRanks
Virax Biolabs Group Ltd (VRAX) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Closing Figures: Virax Biolabs Group Ltd (VRAX)’s Negative Finish at 4.61, Down -15.41 - The Dwinnex
There is no way Virax Biolabs Group Ltd (VRAX) can keep these numbers up - SETE News
Monkeypox Stocks Round 2: Mpox Stocks - Wealth Daily
Virax Biolabs Introduces New Share Purchase Warrant - TipRanks
Pre-market Movers: SQNS, MNTS, UBXG, PRTG, PTWO… - RTTNews
Canadian government forces rail lockout to end - CNN International
Pixie Dust Technologies, Inc. Announces Fiscal Year 2024 Financial Results - Quantisnow
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Fake celebrity endorsements become latest weapon in misinformation wars, sowing confusion ahead of 2024 election - CNN International
Canadian freight railroads shut down, dealing a potential blow to North America’s economy - CNN International
Virax Biolabs Group Ltd (VRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):